Skip to main content
logo
Pharmaron Beijing Co., Ltd. (FRA:17Q1)
Germany flag Germany · Delayed Price · Currency is EUR
2.360
-0.060 (-2.48%)
Last updated: Dec 1, 2025, 8:35 AM CET

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
Laboratory Services
7.05B
Log In
Log In
Log In
Log In
Upgrade
Laboratory Services Growth
5.81%
Log In
Log In
Log In
Log In
Upgrade
Chemical and Formulation Process Development and Production Services
2.99B
Log In
Log In
Log In
Log In
Upgrade
Chemical and Formulation Process Development and Production Services Growth
10.24%
Log In
Log In
Log In
Log In
Upgrade
Clinical Research Services
1.83B
Log In
Log In
Log In
Log In
Upgrade
Clinical Research Services Growth
5.12%
Log In
Log In
Log In
Log In
Upgrade
Macromolecule and Cell and Gene Therapy Services
407.52M
Log In
Log In
Log In
Log In
Upgrade
Macromolecule and Cell and Gene Therapy Services Growth
-4.10%
Log In
Log In
Log In
Log In
Upgrade
Other
6.40M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
38.79%
Log In
Log In
Log In
Log In
Upgrade
Other
6.40M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
38.79%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
Other
39.51M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-19.17%
Log In
Log In
Log In
Log In
Upgrade
North America
7.85B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
6.11%
Log In
Log In
Log In
Log In
Upgrade
Europe
2.27B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
23.18%
Log In
Log In
Log In
Log In
Upgrade
China
1.85B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-6.46%
Log In
Log In
Log In
Log In
Upgrade
Asia
264.27M
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-1.77%
Log In
Log In
Log In
Log In
Upgrade
Other
39.51M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-19.17%
Log In
Log In
Log In
Log In
Upgrade